Results 101 to 110 of about 36,163 (243)

Exploring the long‐term effects of COVID‐19 in patients with epilepsy: A multicenter Italian observational study

open access: yesEpilepsia Open, EarlyView.
Abstract Objective Coronavirus disease‐19 (COVID‐19), caused by SARS‐CoV‐2, has led to a global pandemic since December 2019. People with epilepsy (PwE) face higher risks of severe COVID‐19 outcomes and may be more vulnerable to long‐term neurological and psychiatric effects. Methods This multicenter, retrospective cohort study reviewed medical records
Fedele Dono   +8 more
wiley   +1 more source

Presence of Third Party Observers During Neuropsychological Testing Official Statement of the National Academy of Neuropsychology

open access: bronze, 2000
Bradley N. Axelrod   +7 more
openalex   +1 more source

Abnormalities of thalamus and thalamocortical pathways in patients with refractory epilepsy caused by focal cortical dysplasia – MRI study

open access: yesEpilepsia Open, EarlyView.
Abstract Objective Drug‐resistant epilepsy, a severe and diagnostically challenging neurological condition often linked to focal cortical dysplasia (FCD), represents a significant social and healthcare burden. While the thalamus is notably altered in this disorder, it remains unclear whether these changes result from epilepsy manifestation or ...
David Kala   +12 more
wiley   +1 more source

Facilitators and barriers of antiseizure medication adherence from Australian healthcare providers' perspectives: A qualitative study

open access: yesEpilepsia Open, EarlyView.
Abstract Objectives Antiseizure medications (ASMs) are the mainstay of epilepsy treatment. Two‐thirds of people with epilepsy can become seizure‐free with appropriately selected ASMs. Adherence to ASMs is crucial for achieving seizure control. Unfortunately, treatment gaps prevent many people from accessing or adhering to ASMs.
Alison Conquest   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy